{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:24:09Z","timestamp":1791289449418,"version":"4.3.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-566","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T02:08:09Z","timestamp":1385863689000},"source":"Crossref","is-referenced-by-count":122,"title":["Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Jean-Pierre","family":"Roperch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Incitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Forbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriane","family":"Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Mesli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Baumgaertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iradj","family":"Sobhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,1]]},"reference":[{"issue":"2","key":"4198_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ijc.1440","volume":"94","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden:Globocan 2000. Int J Cancer. 2001, 94 (2): 153-156. 10.1002\/ijc.1440.","journal-title":"Int J Cancer"},{"key":"4198_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bmb\/64.1.1","volume":"64","author":"P Boyle","year":"2002","unstructured":"Boyle P, Leon ME: Epidemiology of colorectal cancer. Br Med Bull. 2002, 64: 1-25. 10.1093\/bmb\/64.1.1.","journal-title":"Br Med Bull"},{"issue":"5","key":"4198_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E: Cancer Statistics, 2010. Cancer J Clin. 2010, 60 (5): 277-300. 10.3322\/caac.20073.","journal-title":"Cancer J Clin"},{"issue":"2","key":"4198_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/gast.2003.50044","volume":"124","author":"S Winawer","year":"2003","unstructured":"Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003, 124 (2): 544-560. 10.1053\/gast.2003.50044.","journal-title":"Gastroenterology"},{"issue":"1","key":"4198_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.gastro.2004.10.041","volume":"128","author":"NK Osborn","year":"2005","unstructured":"Osborn NK, Ahlquist DA: Stool screening for colorectal cancer: molecular approaches. Gastroenterology. 2005, 128 (1): 192-206. 10.1053\/j.gastro.2004.10.041.","journal-title":"Gastroenterology"},{"issue":"7","key":"4198_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/DCR.0b013e31820fd2bc","volume":"54","author":"I Sobhani","year":"2011","unstructured":"Sobhani I, Alzahouri K, Ghout I, Charles DJ, Durand-Zaleski I: Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy. Dis Colon Rectum. 2011, 54 (7): 876-886. 10.1007\/DCR.0b013e31820fd2bc.","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4198_CR7","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1053\/j.gastro.2004.02.018","volume":"126","author":"J Faivre","year":"2004","unstructured":"Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al: Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004, 126 (6): 1674-1680.","journal-title":"Gastroenterology"},{"issue":"15","key":"4198_CR8","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1001\/jama.284.15.1954","volume":"284","author":"AL Frazier","year":"2000","unstructured":"Frazier AL, Colditz GA, Fuchs CS, Kuntz KM: Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000, 284 (15): 1954-1961. 10.1001\/jama.284.15.1954.","journal-title":"JAMA"},{"issue":"33","key":"4198_CR9","doi-asserted-by":"publisher","first-page":"8512","DOI":"10.1200\/JCO.2005.04.0063","volume":"23","author":"CE Desch","year":"2005","unstructured":"Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al: Colorectal cancer surveillance: 2005 update of an American society of clinical oncology practice guideline. J Clin Oncol. 2005, 23 (33): 8512-8519. 10.1200\/JCO.2005.04.0063.","journal-title":"J Clin Oncol"},{"issue":"19","key":"4198_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1056\/NEJM199305133281901","volume":"328","author":"JS Mandel","year":"2005","unstructured":"Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota colon cancer control study. N Engl J Med. 2005, 328 (19): 1365-1371.","journal-title":"N Engl J Med"},{"issue":"4","key":"4198_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10198-007-0083-0","volume":"9","author":"L Clerc","year":"2008","unstructured":"Clerc L, Jooste V, Lejeune C, Schmitt B, Arveux P, Quantin C, et al: Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France. Eur J Health Econ. 2008, 9 (4): 361-367. 10.1007\/s10198-007-0083-0.","journal-title":"Eur J Health Econ"},{"issue":"8648","key":"4198_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(89)92750-5","volume":"1","author":"JD Hardcastle","year":"1989","unstructured":"Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, et al: Ramdomised, controlled trial of faecal occult blood screening for colorectal cancer: results for first 107,349 subjects. Lancet. 1989, 1 (8648): 1160-1164.","journal-title":"Lancet"},{"issue":"1","key":"4198_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/01.cco.0000147383.04709.10","volume":"17","author":"M Esteller","year":"2005","unstructured":"Esteller M: DNA methylation and cancer therapy: new developments and expectations. Curr Opin Oncol. 2005, 17 (1): 55-60. 10.1097\/01.cco.0000147383.04709.10.","journal-title":"Curr Opin Oncol"},{"issue":"7","key":"4198_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/hmg\/10.7.687","volume":"10","author":"SB Baylin","year":"2001","unstructured":"Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG: Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet. 2001, 10 (7): 687-692. 10.1093\/hmg\/10.7.687.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4198_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/gut.2005.088799","volume":"56","author":"JJ Wong","year":"2007","unstructured":"Wong JJ, Hawkins NJ, Ward RL: Colorectal cancer: a model for epigenetic tumorigenesis. Gut. 2007, 56 (1): 140-148. 10.1136\/gut.2005.088799.","journal-title":"Gut"},{"issue":"4","key":"4198_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1586\/14737159.3.4.443","volume":"3","author":"HM Muller","year":"2003","unstructured":"Muller HM, Widschwendter M: Methylated DNA as a possible screening marker for neoplastic disease in several body fluids. Expert Rev Mol Diagn. 2003, 3 (4): 443-458. 10.1586\/14737159.3.4.443.","journal-title":"Expert Rev Mol Diagn"},{"issue":"11 Pt 1","key":"4198_CR17","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1158\/1078-0432.CCR-05-2733","volume":"12","author":"MJ Fackler","year":"2006","unstructured":"Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, et al: Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res. 2006, 12 (11 Pt 1): 3306-3310.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"4198_CR18","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/jnci\/djj265","volume":"98","author":"MO Hoque","year":"2006","unstructured":"Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van CW, et al: Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst. 2006, 98 (14): 996-1004. 10.1093\/jnci\/djj265.","journal-title":"J Natl Cancer Inst"},{"issue":"6726","key":"4198_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/18899","volume":"398","author":"JC Hsieh","year":"1999","unstructured":"Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, et al: A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature. 1999, 398 (6726): 431-436. 10.1038\/18899.","journal-title":"Nature"},{"issue":"18","key":"4198_CR20","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/sj.onc.1208511","volume":"24","author":"B He","year":"2005","unstructured":"He B, Reguart N, You L, Mazieres J, Xu Z, Lee AY, et al: Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene. 2005, 24 (18): 3054-3058. 10.1038\/sj.onc.1208511.","journal-title":"Oncogene"},{"issue":"53","key":"4198_CR21","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.1038\/sj.onc.1208910","volume":"24","author":"H Taniguchi","year":"2005","unstructured":"Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, et al: Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene. 2005, 24 (53): 7946-7952. 10.1038\/sj.onc.1208910.","journal-title":"Oncogene"},{"issue":"1","key":"4198_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2003.10.024","volume":"206","author":"M Cebrat","year":"2004","unstructured":"Cebrat M, Strzadala L, Kisielow P: Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells. Cancer Lett. 2004, 206 (1): 107-113. 10.1016\/j.canlet.2003.10.024.","journal-title":"Cancer Lett"},{"issue":"21","key":"4198_CR23","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3748\/wjg.15.2595","volume":"15","author":"Z Ding","year":"2009","unstructured":"Ding Z, Qian YB, Zhu LX, Xiong QR: Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol. 2009, 15 (21): 2595-2601. 10.3748\/wjg.15.2595.","journal-title":"World J Gastroenterol"},{"key":"4198_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1172\/JCI37175","volume":"119","author":"M Kansara","year":"2009","unstructured":"Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, et al: Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. Clin Invest. 2009, 119: 837-851. 10.1172\/JCI37175.","journal-title":"Clin Invest"},{"key":"4198_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1756-9966-29-26","volume":"29","author":"Z Yang","year":"2010","unstructured":"Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J: Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas. J Exp Clin Cancer Res. 2010, 29: 26-10.1186\/1756-9966-29-26.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"4198_CR26","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/carcin\/bgr193","volume":"32","author":"AL Delmas","year":"2011","unstructured":"Delmas AL, Riggs BM, Pardo CE, Dyer LM, Darst RP, Izumchenko EG, et al: WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix. Carcinogenesis. 2011, 32 (11): 1625-1633. 10.1093\/carcin\/bgr193.","journal-title":"Carcinogenesis"},{"key":"4198_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/path.1449","volume":"201","author":"C Wissmann","year":"2003","unstructured":"Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, et al: WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol. 2003, 201: 204-212. 10.1002\/path.1449.","journal-title":"J Pathol"},{"issue":"14","key":"4198_CR28","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1158\/0008-5472.CAN-04-1389","volume":"64","author":"J Mazieres","year":"2004","unstructured":"Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, et al: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res. 2004, 64 (14): 4717-4720. 10.1158\/0008-5472.CAN-04-1389.","journal-title":"Cancer Res"},{"key":"4198_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1471-2407-9-217","volume":"9","author":"J Veeck","year":"2009","unstructured":"Veeck J, Wild PJ, Fuchs T, Schuffler PJ, Hartmann A, Kn\u00fcchel R, Dahl E: Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC cancer. 2009, 9: 217-10.1186\/1471-2407-9-217.","journal-title":"BMC cancer"},{"issue":"7","key":"4198_CR30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/neuonc\/nor036","volume":"13","author":"WL Lambiv","year":"2011","unstructured":"Lambiv WL, Vassallo I, Delorenzi M, Shay T, Diserens AC, Misra A, et al: The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence. Neuro Oncol. 2011, 13 (7): 736-747. 10.1093\/neuonc\/nor036.","journal-title":"Neuro Oncol"},{"issue":"19","key":"4198_CR31","doi-asserted-by":"publisher","first-page":"6185","DOI":"10.1158\/1078-0432.CCR-09-0111","volume":"15","author":"BB Lee","year":"2009","unstructured":"Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, et al: Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res. 2009, 15 (19): 6185-6191. 10.1158\/1078-0432.CCR-09-0111.","journal-title":"Clin Cancer Res"},{"issue":"35","key":"4198_CR32","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1038\/sj.onc.1205597","volume":"21","author":"PA Jones","year":"2002","unstructured":"Jones PA: DNA methylation and cancer. Oncogene. 2002, 21 (35): 5358-5360. 10.1038\/sj.onc.1205597.","journal-title":"Oncogene"},{"key":"4198_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/jcp.2004.018598","volume":"58","author":"T Byun","year":"2005","unstructured":"Byun T, Karimi M, Marsh JL, Milovanovic T, Lin F, Holcombe RF: Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J Clin Pathol. 2005, 58: 515-519. 10.1136\/jcp.2004.018598.","journal-title":"J Clin Pathol"},{"key":"4198_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/359235a0","volume":"359","author":"SM Powell","year":"1992","unstructured":"Powell SM, et al: APC mutations occur early during colorectal tumorigenesis. Nature. 1992, 359: 235-237. 10.1038\/359235a0.","journal-title":"Nature"},{"key":"4198_CR35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1101\/gad.287404","volume":"18","author":"OJ Sansom","year":"2004","unstructured":"Sansom OJ, et al: Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004, 18: 1385-1390. 10.1101\/gad.287404.","journal-title":"Genes Dev"},{"key":"4198_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","volume":"20","author":"CY Logan","year":"2004","unstructured":"Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004, 20: 781-810. 10.1146\/annurev.cellbio.20.010403.113126.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"57","key":"4198_CR37","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1038\/sj.onc.1210059","volume":"25","author":"S Segditsas","year":"2006","unstructured":"Segditsas S, Tomlinson I: Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene. 2006, 25 (57): 7531-7537. 10.1038\/sj.onc.1210059.","journal-title":"Oncogene"},{"issue":"2","key":"4198_CR38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.gastro.2005.06.007","volume":"129","author":"A Gregorieff","year":"2005","unstructured":"Gregorieff A, Pinto D, Begthel H, Destree O, Kielman M, Clevers H: Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology. 2005, 129 (2): 626-638.","journal-title":"Gastroenterology"},{"key":"4198_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2174\/156652406777435417","volume":"6","author":"AO Chan","year":"2006","unstructured":"Chan AO, Rashid A: CpG island methylation in precursors of gastrointestinal malignancies. Curr Mol Med. 2006, 6: 401-408. 10.2174\/156652406777435417.","journal-title":"Curr Mol Med"},{"issue":"1","key":"4198_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1385\/ENDO:22:1:49","volume":"22","author":"SP Kalra","year":"2003","unstructured":"Kalra SP, Kalra PS: Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine. 2003, 22 (1): 49-56. 10.1385\/ENDO:22:1:49.","journal-title":"Endocrine"},{"issue":"8","key":"4198_CR41","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/oby.2002.106","volume":"10","author":"O Ukkola","year":"2002","unstructured":"Ukkola O, Ravussin E, Jacobson P, Perusse L, Rankinen T, Tschop M, et al: Role of ghrelin polymorphisms in obesity based on three different studies. Obes Res. 2002, 10 (8): 782-791. 10.1038\/oby.2002.106.","journal-title":"Obes Res"},{"issue":"9612","key":"4198_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008, 371 (9612): 569-578. 10.1016\/S0140-6736(08)60269-X.","journal-title":"Lancet"},{"key":"4198_CR43","doi-asserted-by":"publisher","first-page":"27914","DOI":"10.1074\/jbc.274.39.27914","volume":"274","author":"G Hallden","year":"1999","unstructured":"Hallden G, Hadi M, Hong HT, Aponte GW: Y receptor-mediated induction of CD63 transcripts, a tetraspanin determined to be necessary for differentiation of the intestinal epithelial cell line, hBRIE 380i cells. J Biol Chem. 1999, 274: 27914-27924. 10.1074\/jbc.274.39.27914.","journal-title":"J Biol Chem"},{"key":"4198_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0304-3835(97)81762-4","volume":"119","author":"M Ogasawara","year":"1997","unstructured":"Ogasawara M, Murata J, Ayukawa K, Saiki I: Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Cancer Lett. 1997, 119: 125-130. 10.1016\/S0304-3835(97)81762-4.","journal-title":"Cancer Lett"},{"key":"4198_CR45","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1631\/jzus.2007.B0853","volume":"8","author":"AJ Liu","year":"2007","unstructured":"Liu AJ, Furusato B, Ravindranath L, Chen YM, Srikantan V, McLeod DG, Petrovics G, Srivastava S: Quantitative analysis of a panel of gene expression in prostate cancer with emphasis on NPY expression analysis. J Zhejiang Univ Sci B. 2007, 8: 853-859. 10.1631\/jzus.2007.B0853.","journal-title":"J Zhejiang Univ Sci B"},{"key":"4198_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000139124","volume":"74","author":"M Abe","year":"2008","unstructured":"Abe M, Watanabe N, McDonell N, Takato T, Ohira M, Nakagawara A, Ushijima T: Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology. 2008, 74: 50-60. 10.1159\/000139124.","journal-title":"Oncology"},{"issue":"8","key":"4198_CR47","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3346\/jkms.2010.25.8.1152","volume":"25","author":"SH Shin","year":"2010","unstructured":"Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH: Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. J Korean Med Sci. 2010, 25 (8): 1152-1159. 10.3346\/jkms.2010.25.8.1152.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"4198_CR48","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1152\/ajpcell.00358.2010","volume":"300","author":"S DeMorrow","year":"2011","unstructured":"DeMorrow S, Onori P, Venter J, Invernizzi P, Frampton G, White M, Franchitto A, et al: Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion. Am J Physiol Cell Physiol. 2011, 300 (5): 1078-1089. 10.1152\/ajpcell.00358.2010.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"4198_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1124\/pr.56.3.2","volume":"56","author":"I Tegeder","year":"2004","unstructured":"Tegeder I, Geisslinger G: Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol Rev. 2004, 56 (3): 351-369. 10.1124\/pr.56.3.2.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"4198_CR50","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1083\/jcb.130.6.1251","volume":"130","author":"A Bottger","year":"1995","unstructured":"Bottger A, Spruce BA: Proenkephalin is a nuclear protein responsive to growth arrest and differentiation signals. J Cell Biol. 1995, 130 (6): 1251-1262. 10.1083\/jcb.130.6.1251.","journal-title":"J Cell Biol"},{"issue":"9","key":"4198_CR51","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/sj.cdd.4402172","volume":"14","author":"N Mc Tavish","year":"2007","unstructured":"Mc Tavish N, Copeland LA, Saville MK, Perkins ND, Spruce BA: Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-KappaB and p53-related genes targets. Cell Death Differ. 2007, 14 (9): 1700-1710. 10.1038\/sj.cdd.4402172.","journal-title":"Cell Death Differ"},{"issue":"4937","key":"4198_CR52","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1126\/science.2512642","volume":"246","author":"JL Sonneberg","year":"1989","unstructured":"Sonneberg JL, Rauscher FJ, Morgan JI, Curran T: Regulation of proenkephalin by fos and Jun. Science. 1989, 246 (4937): 1622-1625. 10.1126\/science.2512642.","journal-title":"Science"},{"key":"4198_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2490-5-17","volume":"5","author":"YA Goo","year":"2005","unstructured":"Goo YA, Goodlett DR, Pascal LE, et al: Stromal mesenchyme cell genes of the human prostate and bladder. BMC Urol. 2005, 5: 17-10.1186\/1471-2490-5-17.","journal-title":"BMC Urol"},{"issue":"7","key":"4198_CR54","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-11-0067","volume":"20","author":"W Chung","year":"2011","unstructured":"Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, Issa JP: Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers. 2011, 20 (7): 1483-1491. 10.1158\/1055-9965.EPI-11-0067.","journal-title":"Cancer Epidemiol Biomarkers"},{"issue":"23","key":"4198_CR55","first-page":"8540","volume":"61","author":"T Ueki","year":"2001","unstructured":"Ueki T, Toyata M, Skinner H, et al: Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res. 2001, 61 (23): 8540-8546.","journal-title":"Cancer Res"},{"issue":"5","key":"4198_CR56","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/S0002-9440(10)61104-2","volume":"160","author":"N Fukushima","year":"2002","unstructured":"Fukushima N, Sato N, Ueki T, et al: Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol. 2002, 160 (5): 1573-1581. 10.1016\/S0002-9440(10)61104-2.","journal-title":"Am J Pathol"},{"issue":"5\u20136","key":"4198_CR57","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molonc.2009.03.004","volume":"3","author":"AC Tan","year":"2009","unstructured":"Tan AC, Jimeno A, Lin SH, Wheelhouse J, Chan F, Solomon A, et al: Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol. 2009, 3 (5\u20136): 425-438.","journal-title":"Mol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-566.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-566\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T19:52:41Z","timestamp":1468353161000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4198"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-566","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"566"}}